These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2471013)

  • 21. The mode of action of alpha 1-adrenoceptor blockers on blood lipids.
    Jansen H
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():20-2. PubMed ID: 2148192
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys.
    Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ
    Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of doxazosin on cholesterol synthesis in cell culture.
    D'Eletto RD; Javitt NB
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S1-4; discussion S4. PubMed ID: 2471008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A; Daae LN; Kierulf P; Brusletto B; Holme I; Syvertsen JO
    J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of doxazosin with insulin or glucagon in the ob/ob mouse.
    Swindell AC; Valentine JJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S20-4; discussion S24. PubMed ID: 2471011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters.
    Tréguier M; Briand F; Boubacar A; André A; Magot T; Nguyen P; Krempf M; Sulpice T; Ouguerram K
    Eur J Clin Invest; 2011 Sep; 41(9):921-8. PubMed ID: 21299553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dietary cholesterol and fasting on hamster plasma lipoprotein lipids.
    Weingand KW; Daggy BP
    Eur J Clin Chem Clin Biochem; 1991 Jul; 29(7):425-8. PubMed ID: 1932362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of serum lipids in hypercholesterolaemic rabbits treated with doxazosin.
    Leren TP; Berg K
    Scand J Clin Lab Invest; 1988 Jun; 48(4):313-7. PubMed ID: 2907180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of psyllium on plasma total and lipoprotein cholesterol and hepatic cholesterol in hamsters fed n-3 PUFA or n-6 PUFA with high cholesterol levels.
    Liu YC; Liu SY; Lin MH
    Ann Nutr Metab; 2004; 48(6):374-80. PubMed ID: 15564767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    Frick MH; Cox DA; Himanen P; Huttunen M; Pitkäjärvi T; Pörsti P; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
    Am J Cardiol; 1987 May; 59(14):61G-67G. PubMed ID: 2884854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS; Hirokawa WT
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of long-term exercise and high-cholesterol diet on lipid-lipoprotein metabolism in rats.
    Terao T; Fujise T; Nakano S
    Tokai J Exp Clin Med; 1987 Nov; 12(4):243-51. PubMed ID: 3503394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of soya milk and Bifidobacterium-fermented soya milk on plasma and liver lipids, and faecal steroids in hamsters fed on a cholesterol-free or cholesterol-enriched diet.
    Kikuchi-Hayakawa H; Onodera N; Matsubara S; Yasuda E; Shimakawa Y; Ishikawa F
    Br J Nutr; 1998 Jan; 79(1):97-105. PubMed ID: 9505807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of different dietary fats and cholesterol on serum lipoprotein concentrations in hamsters.
    Sessions VA; Salter AM
    Biochim Biophys Acta; 1994 Mar; 1211(2):207-14. PubMed ID: 8117748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic alpha 1-adrenergic blockade, serum triacylglycerols, and tissue lipoprotein lipase activity in rats fed diets high in starch or sucrose.
    Deshaies Y; Martineau MJ; LaLonde J
    Nutrition; 1991; 7(2):109-15; discussion 115-6. PubMed ID: 1686980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The amount of dietary cholesterol changes the mode of effects of (n-3) polyunsaturated fatty acid on lipoprotein cholesterol in hamsters.
    Lin MH; Lu SC; Huang PC; Liu YC; Liu SY
    Ann Nutr Metab; 2004; 48(5):321-8. PubMed ID: 15467282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA; Brogden RN
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of selective alpha1-inhibition in lipid metabolism. Role of doxazosin. Proceedings of an international workshop. Puerto Rico, April 16, 1988.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S1-52. PubMed ID: 2471009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.